Gene: TSPYL2
Official Full Name: TSPY like 2provided by HGNC
Gene Summary: This gene encodes a member of the testis-specific protein Y-encoded, TSPY-like/SET/nucleosome assembly protein-1 superfamily. The encoded protein is localized to the nucleolus where it functions in chromatin remodeling and as an inhibitor of cell-cycle progression. This protein may play a role in the suppression of tumor growth. [provided by RefSeq, Sep 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20823 | TSPYL2 Knockout cell line (HeLa) | Human | TSPYL2 | 1:3~1:6 | Negative | Online Inquiry |
KO20824 | TSPYL2 Knockout cell line (HCT 116) | Human | TSPYL2 | 1:2~1:4 | Negative | Online Inquiry |
KO20825 | TSPYL2 Knockout cell line (HEK293) | Human | TSPYL2 | 1:3~1:6 | Negative | Online Inquiry |
KO20826 | TSPYL2 Knockout cell line (A549) | Human | TSPYL2 | 1:3~1:4 | Negative | Online Inquiry |
TSPYL2 Gene Knockout Cell Lines are meticulously engineered cellular models that involve the targeted disruption of the TSPYL2 gene, a gene implicated in various biological processes including cell cycle regulation and differentiation. These knockout cell lines provide researchers with a powerful tool for studying the functional role of TSPYL2 and its contributions to cellular pathways and oncogenesis.
The primary function of TSPYL2 involves its regulation of gene expression and interaction with proteins associated with cell cycle control. By employing CRISPR-Cas9 technology or other genetic editing methods, these knockout cell lines facilitate the study of TSPYL2's impact on cellular proliferation, apoptosis, and overall physiology. Researchers utilize these models to decode the genetic underpinnings of diseases, particularly in cancer research, as alterations in TSPYL2 expression may correlate with tumorigenesis.
In research and clinical settings, the importance of TSPYL2 Gene Knockout Cell Lines cannot be overstated. They serve as an excellent platform for drug screening, functional genomics, and validation of therapeutic targets. The ability to precisely manipulate the genetic make-up of these cells opens avenues for uncovering novel interactions and therapeutic interventions that could lead to advancements in treatment protocols for various malignancies.
A key advantage of utilizing TSPYL2 Gene Knockout Cell Lines lies in their specificity and reproducibility, offering higher accuracy compared to random mutagenesis approaches. These models foster an enhanced understanding of TSPYL2's role in cellular behavior while minimizing background variability, thus amplifying the robustness of experimental outcomes.
Researchers, clinicians, and biopharmaceutical companies can significantly benefit from the insights gained through these knockout models, fueling innovative approaches in precision medicine and targeted therapies. By selecting our TSPYL2 Gene Knockout Cell Lines, users gain access to cell lines backed by rigorous scientific validation, complemented by our company's extensive expertise in genetic engineering and biotechnology, ensuring reliable and high-quality products that propel biological research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.